Skip to main content

Table 3 Medium titers of possible biomarkers in the SLE, RA and control groups

From: Cognitive dysfunction in systemic lupus erythematosus is associated with disease activity and oxidative stress: a comparative study with rheumatoid arthritis for identifying biomarkers

Kruskal-Wallis (p)

       

Biomarkers

SLE

RA

Controls

All groups

SLE/RA

AR/

Controls

SLE/Controls

S100ß

395.88 ± 406.6 (223.5)

595.32 ± 1166.53

(218.16)

677.85 ± 1339.13

(223.5)

0.862

   

IL-6

532.39 ± 205.61(341.88)

485.99 ± 182.01

(485.42)

595.24 ± 477.34(445.08)

0.612

   

MDA

5.20 ± 5.92(4,15)

7.24 ± 4.92(6.8)

6.58 ± 4.47(6.54)

0.010

0.016

1,0

0.063

MPO

15.41 ± 18.96(8.16)

13.66 ± 17.28(5.02)

4.89 ± 5.86(1.57)

0.013

1,0

0.102

0.014

GSHr

88.48 ± 68.01(60.64)

94.74 ± 104.89(59.69)

79.15 ± 61.55(50.97)

0.50

   
  1. Data expressed in Mean ± Standard Deviation (Median). IL-6: -Interleukin 6, S100ß, MPO: myeloperoxidase, MDA: malondialdehyde, GSHr: reduced glutathione. Statistically significant p-values ​​are highlighted in bold
Back to article page

BMC Neuroscience

ISSN: 1471-2202

Contact us